Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting response to hepatitis C therapy.

The Journal of clinical investigation - 1 Jan 2009

Oh Thomas S, Rice Charles M

Abstract excerpt

Current treatment for chronic hepatitis C is expensive, is often accompanied by burdensome side effects, and, sadly, fails in almost half of cases. The ability to predict such failures prior to treatment could save a great deal of pain and expense for the patient with HCV. In this issue of the JCI, Aurora and colleagues describe the development of genetic markers predictive of treatment response based on a study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Biomarkers
Share to Genome, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Predictive Value of Tests

Share to Sequence Alignment

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 19104144
DOI: 10.1172/JCI38069
PMCID: PMC2613453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting response to hepatitis C therapy.PMID 19104144Read ↗

Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans.Semantic proximity Read ↗

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortSemantic proximity Read ↗

Prediction of prognostic biomarkers for interferon-based therapy to hepatitis C virus patients: a meta-analysis of the NS5A protein in subtypes 1a, 1b, and 3a.Semantic proximity Read ↗

Coevolution of the Hepatitis C Virus Polyprotein Sites in Patients on Combined Pegylated Interferon and Ribavirin TherapySemantic proximity Read ↗

A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus.Semantic proximity Read ↗

Genetics, Genomics, and Proteomics: Implications for the Diagnosis and the Treatment of Chronic Hepatitis CSemantic proximity Read ↗

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.Semantic proximity Read ↗

Toward the establishment of a prediction system for the personalized treatment of chronic hepatitis C.Semantic proximity Read ↗

Predictors of hepatitis C treatment response: what's new?Semantic proximity Read ↗

Host genetic variants influencing the clinical course of hepatitis C virus infection.Semantic proximity Read ↗

Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine.Semantic proximity Read ↗

Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.